THE BIG IMPORTANCE
OF ULTRA-SMALL
THINGS.

Done in seconds, not hours.

We achieved what was previously unachievable by giving patients a better way to receive, experience, and benefit from life-saving biologics. Our hyper concentration microparticle platform, Hypercon™, resolves the formulating and volume delivery limitations associated with intravenous biologic therapies by developing low-volume, stable, hyper concentrated biologic formulations for subcutaneous delivery.

Our methodology and approach are gentle, and we honor an asset’s integrity and efficacy. We preserve a protein’s beauty — it’s quality, shape, and size.

Our proprietary formulation development strategy consistently yields innovative high-quality products to solve the modern-day challenges of intravenous treatments.

Our microparticle suspension technology platform can be adapted to nearly any protein therapeutic.

A first-of-its-kind microparticle
platform technology, achieving solutions that have unmatched syringeability with the highest protein load.


Up to 700 mg/ml
5x greater concentration level versus standard formulations


Molecules and asset-specific customization


Vials, pre-filled syringes, cartridges, and auto-injector compatibility


Room temperature manufacturing process


Superior stability

We have created
a path that has yet to be charted.